EPITUMOMAB CITUXETAN
UNII 07HB886F99

Substance Identification & Data

This profile provides standardized clinical and technical data for Epitumomab Cituxetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 07HB886F99.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 263547-71-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
07HB886F99
CAS Registry Number
263547-71-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EPITUMOMAB CITUXETAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C175781
National Cancer Institute reference terminology for clinical and research data.
INN ID
8372
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Epitumomab Cituxetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EPITUMOMAB CITUXETAN

Common Names & Synonyms

EPITUMOMAB CITUXETAN [INN]
HMFG 1

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN EPISIALIN) (MOUSE MONOCLONAL HMFG-1 .GAMMA.1-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL HMFG-1, DIMER, N6-(((4-(2-(BIS(CARBOXYMETHYL)AMINO)-3-((2-(BIS(CARBOXYMETHYL)AMINO)ETHYL)(CARBOXYMETHYL)AMINO)PROPYL)PHENYL)AMINO)THIOXOMETHYL)-L-LYSINE CONJUGATE

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus